Company: ZURA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001410578-25-001783
Chunk: 4

Company: Zura Bio Ltd
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 4
---
Item 1. Financial Statements.

Zura Bio Limited

Condensed Consolidated Balance Sheets

(In thousands, except share data)

​​​​​​​​    June 30,     December 31, ​​2025​2024​​(unaudited)​​​Assets​​​​​​Current assets ​​​​  Cash and cash equivalents​$ 154,490​$ 176,498Prepaid expenses and other current assets​​ 2,495​​ 2,246Total current assets​​ 156,985​​ 178,744Property and equipment, net​​ 122​​ 91Other assets​​ 698​​ 698Total assets​$ 157,805​$ 179,533​​​​​​​Liabilities, Redeemable Noncontrolling Interest and Shareholders’ Equity​​​​​​Current liabilities​​​​​​Accounts payable and accrued expenses​$ 18,696​$ 19,514Total current liabilities​​ 18,696​​ 19,514Total liabilities​​ 18,696​​ 19,514​​​​​​​Commitments and contingencies (Note 9)​​​​​​​​​​​​​Redeemable noncontrolling interest​​ 11,663​​ 11,663​​​​​​​Shareholders’ Equity​​​​​​Preferred shares, $0.0001 par value, 1,000,000 shares authorized as of June 30, 2025 and December 31, 2024; no shares issued and outstanding as of June 30, 2025 and December 31, 2024​​—​​—Class A Ordinary Shares, $0.0001 par value; 300,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 62,064,270 and 65,297,530 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively​​ 6​​ 7Additional paid-in capital​​ 315,231​​ 302,705Accumulated deficit​​ (189,332)​​ (155,897)Total Zura Bio Limited shareholders’ equity ​​ 125,905​​ 146,815Noncontrolling interest​​ 1,541​​ 1,541Total shareholders’ equity ​​ 127,446​​ 148,356Total liabilities, redeemable noncontrolling interest and shareholders’ equity ​$ 157,805​$ 179,533